Navigation Links
IV Aspirin Drip Appears to Be Safe, Effective for Migraine
Date:9/20/2010

MONDAY, Sept. 20 (HealthDay News) -- The intravenous administration of aspirin appears to be a safe and effective way to treat hospitalized patients suffering from either severe headaches or migraines, new research indicates.

Study author Dr. Peter J. Goadsby, of the Headache Group in the department of neurology at the University of California, San Francisco, described his team's findings in the Sept. 21 issue of Neurology.

"Intravenous aspirin is not readily available in the United States, and only on a 'named patient' basis in the United Kingdom," Goadsby noted in a news release from the American Academy of Neurology. The 'named patient' program is for those who have exhausted approved treatment options and do not qualify for a clinical trial.

Pointing out that use of intravenous (IV) aspirin is not uncommon in other parts of continental Europe, Goadsby added that his team's results "show it could be a cost-effective, safe and easy-to-use treatment for people hospitalized for headache or migraine."

To explore the IV aspirin treatment option, the study authors focused on 168 patients (including 117 women) between the ages of 18 and 75 who had been hospitalized for severe headaches or migraines. All were given 1 gram of aspirin via a drip, for an average of five doses.

Most of the patients had been diagnosed with a migraine, and almost all were also diagnosed with a "chronic daily headache," meaning that they had suffered from a headache for at least 15 days out of each of the prior three months.

All of the patients knew they were being treated with aspirin. And each study participant kept a pain diary during the process, rating pain on a 10-point scale ranging from mild to moderate to severe.

The researchers found that in more than 25 percent of the treatments, the IV aspirin caused pain to drop down a full category, namely from severe to moderate, moderate to mild, or mild to no headache.

About 40 percent of treatments had a "moderate effect" on participants' pain levels, the findings showed.

Side effects from the treatment included heartburn, nausea, vomiting, bleeding, worsening of asthma, kidney impairment and rash.

"Our findings warrant more research into the use of IV aspirin for severe headache or migraine," Goadsby stated in the news release.

Although Goadsby noted that prior research had similarly illustrated the apparent benefits of IV aspirin by comparing pain levels against a second pool of patients who did not get the treatment, Dr. Carl Stafstrom, a professor of neurology and pediatrics at the University of Wisconsin-Madison, pointed out that the current effort did not do so.

"And certainly I would want to see this approach tested with such a 'control group' to make sure that the treatment is truly safe as well as effective," Stafstrom cautioned.

"But it's an encouraging response," he added. "And there's certainly a need for new and improved treatment modalities for acute headaches among hospitalized patients. So I would say that any new treatment is welcome. But this needs more exploration."

More information

For more on migraine and headache treatment, visit the American Academy of Family Physicians.

-- Alan Mozes

SOURCES: American Academy of Neurology, news release, Sept. 14, 2010; Carl Stafstrom, M.D., Ph.D., professor, neurology and pediatrics, University of Wisconsin-Madison


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Aspirin May Boost Breast Cancer Survival
2. Cardiologists Comment on Aspirin Versus Resveratrol
3. Aspirin Alone Works Best to Prevent Clots a Year After Stenting
4. Aspirin May Increase Risk of Crohns Disease
5. Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later
6. Aspirin recommendations changed for many younger diabetic patients
7. Can aspirin prolong a healthy life?
8. Low-Dose Aspirin May Reduce Colon Cancer Risk
9. Protein Appears Key to Intestinal Balance
10. How health care is paid for appears to impact outcome
11. Hospitalization Appears to Help Personality Disorder Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IV Aspirin Drip Appears to Be Safe, Effective for Migraine
(Date:3/24/2017)... ... , ... The iaedp Foundation, the premier provider of educational programs and training ... the full spectrum of disordered eating, announced today that the 2017 Symposium set a ... states and several countries converged on the Green Valley Resort in Las Vegas. ...
(Date:3/24/2017)... ... March 24, 2017 , ... In just two ... Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone so ... nearly 2,000 consumers (and counting) already backing the campaign. , “We are ...
(Date:3/24/2017)... Oakland, CA (PRWEB) , ... March 24, 2017 ... ... present on two panels at the Advanced ERISA Benefit Claims Litigation seminar in ... and Creating the Administrative Record, The majority of cases litigated under ERISA involve ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding Christ Through Social ... devotional journal chronicling the writer’s path toward true communion with God. “Finding Christ ... #TruthwithGrace” is the creation of published author Lea Michelle Johnson, a follower of ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... N.H. , March 24, 2017 New ... the recipient of an award including funding and in-kind ... blood draw technology.  "Making blood draws ... to making their whole hospital experience better.  We,re looking ... this technology can help improve care for the kids ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... Consumer Strategies" report to their offering. ... Pain Management in ... treat their physical pain, emphasizing consumer survey analysis, including trends ... and adults who have selected illnesses/conditions strongly associated with physical ...
(Date:3/24/2017)... 2017 ShangPharma, a leading life ... drug development and discovery services, technology, and ... announced today the intent for a strategic ... consolidating the Contract Research Organizations (CRO) and ... These entities include ChemPartner Shanghai, ChemPartner Fengxian, ...
Breaking Medicine Technology: